Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David J. Kwiatkowski

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

JAMA Oncology
Cancer ResearchOncology
2018English

Renal Cell Carcinoma in Tuberous Sclerosis Complex

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2014English

mTOR Inhibitors in Cancer: What Can We Learn From Exceptional Responses?

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Survival Benefit and Phenotypic Improvement by Hamartin Gene Therapy in a Tuberous Sclerosis Mouse Brain Model

Neurobiology of Disease
Neurology
2015English

Equivalent Benefit of Rapamycin and a Potent mTOR ATP-Competitive Inhibitor, MLN0128 (INK128), in a Mouse Model of Tuberous Sclerosis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2013English

McL1 and DEDD Promote Urothelial Carcinoma Progression

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Extrarenal Perivascular Epithelioid Cell Tumors (PEComas) Respond to mTOR Inhibition: Clinical and Molecular Correlates

International Journal of Cancer
Cancer ResearchOncology
2012English

Rapamycin-Induced miR-21 Promotes Mitochondrial Homeostasis and Adaptation in mTORC1 Activated Cells

Oncotarget
Oncology
2017English

mTORC1-S6K Activation by Endotoxin Contributes to Cytokine Up-Regulation and Early Lethality in Animals

PLoS ONE
Multidisciplinary
2010English

Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy